Skip to main content

Table 1 Clinical characteristics of patients

From: The differences between insulin glargine U300 and insulin degludec U100 in impact on the glycaemic variability, arterial stiffness and the lipid profiles in insulin naïve patients suffering from type two diabetes mellitus – outcomes from cross‐over open-label randomized trial

Total number

23 (16 men)

 

Parameter

Mean

(± SD)

Age (years old)

57.45

6.89

Duration of diabetes (years)

9.71

4.95

Body weight (kg)

89.37

14.30

Body height (cm)

175.35

9.64

Body mass index (kg/m2)

29.30

3.83

Waist circumference (cm)

103.48

8.63

HbA1c (%)

9.67

1.67

Fasting glucose (mmol/L)

12.98

4.51

Serum creatinine (µmol/L)

67.22

13.18

Serum uric acid (µmol/L)

307.57

62.10

Total cholesterol (mmol/L)

5.07

1.10

HDL

1.08

0.23

LDL

3.02

1.00

TG

2.29

0.83

  1. SD standard deviation; HDL high density lipoprotein; LDL low density lipoproteinl; TG triglycerides